Valproate embryopathy — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Valproate embryopathy
Valproate embryopathy: NTDs (1-2%), characteristic facies, cardiac defects, ID and autism risk. Avoid valproate in childbearing women.
Reference: RACP Paediatric Curriculum – Genetics; Australian Therapeutic Guidelines – 2024